Epstein-barr virus-associated intracranial leiomyosarcoma in an HIV-positive adolescent

Journal of Pediatric Hematology/Oncology

Volumn 32, Issue 4, 2010, Pages e144-e147

  Gupta, Sweta ^a   Havens, Peter L ^a   Southern, James F ^b   Firat, Selim Y ^b   Jogal, Sachin S ^a  

^a Children’s Hospital of Wisconsin ^*  (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Brain; Epstein barr virus; Human immunodeficiency virus; Leiomyosarcoma

Indexed keywords

GEMCITABINE; VIRUS RNA;

ADOLESCENT; AFRICAN AMERICAN; ARTICLE; BRAIN CANCER; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CASE REPORT; DRUG WITHDRAWAL; EPSTEIN BARR VIRUS INFECTION; FEMALE; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INOPERABLE CANCER; LEIOMYOSARCOMA; NEUTROPENIA; PRIORITY JOURNAL; SKIN INFECTION; SKIN NECROSIS; SKIN ULCER; STEREOTACTIC BIOPSY; BRAIN TUMOR; EPSTEIN BARR VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; IN SITU HYBRIDIZATION; ISOLATION AND PURIFICATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; TREATMENT OUTCOME; VIROLOGY;

ADOLESCENT; BRAIN NEOPLASMS; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; HERPESVIRUS 4, HUMAN; HIV SEROPOSITIVITY; HIV-1; HUMANS; IN SITU HYBRIDIZATION; LEIOMYOSARCOMA; MAGNETIC RESONANCE IMAGING; RNA, VIRAL; TREATMENT OUTCOME;

EID: 77952768659     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/MPH.0b013e3181c80bf3     Document Type: Article

References (26)

1. SEER Program, National Cancer Institute. Age-Adjusted and Age-Specific SEER Cancer Incidence Rates, 2002-2006 by International Classification of Childhood Cancer (ICCC) Group and Subgroup and Age. Available at: http://www.seer.cancer.gov/csr, accessed on 09/18/09
2. McClain KL, Leach CT, Jenson HB, et al. Association of Epstein Barr Virus with leiomyosarcoma in young people with AIDS. NEJM. 1995; 332: 12-18.
3. Biggar RJ, Frisch M, Goedert JJ, et al. Risk of cancer in children with AIDS. AIDS Cancer Match Registry Group. JAMA. 2000; 284: 205-209.
4. Paulus W, Slowik F, Jellinger K, et al. Primary intracranial sarcomas: histopathological features of 19 cases. Histopathology. 1991; 18: 395-402.
5. Brown HG, Burger PC, Olivi A, et al. Intracranial leiomyosarcoma in a patient with AIDS. Neuroradiology. 1999; 41: 35-39.
6. Bejjani GK, Stopak B, Schwartz A, et al. Primary dural leiomyosarcoma in a patient infected with human immunodeficiency virus: case report. Neurosurgery. 1999; 44: 199-202.
7. Wong K, Chan KC, Lee S, et al. Epstein Barr virus associated smooth muscle tumor in patients with acquired immunodeficiency syndrome. J Microbiol Immunol Infect. 2007; 40: 173-177.
8. Suankratay C, Shuangshoti S, Mutirangura A, et al. Epstein-Barr virus infection-associated smooth-muscle tumors in patients with AIDS. CID. 2005; 40: 1521-1528.
9. Anderson P, Aguilera D, Pearson M, et al. Outpatient chemotherapy plus radiotherapy in sarcomas: improving cancer control with radiosensitizing agents. Cancer Control. 2008; 15: 38-46.
10. Mierau GW, Greffe BS, Weeks DA, et al. Primary leiomyosarcoma of brain in an adolescent with common variable immunodeficiency syndrome. Ultrastruct Pathol. 1997; 21: 301-305.
11. Kumar S, Santi M, Vezina G, et al. Epstein-Barr virus associated smooth muscle tumor of the basal ganglia in an HIV+child: case report and review of literature. Ped Dev Path. 2004; 7: 198-203.
12. Maso LD, Polesel J, Serraino D, et al. Pattern of cancer risk in persons with AIDS in Italy in the HAART era. Brit J Cancer. 2009; 100: 840-847.
13. International Collaboration on HIV and Cancer Epidemiology Unit, Imperial Cancer Research Fund (ICRF), Oxford, UK. Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults. J Natl Cancer Ins. 2000; 92: 1823-1830.
14. Lee ES, Locker J, Nalesnik M, et al. The association of Epstein Barr Virus with smooth muscle tumors occurring after organ transplantation. NEJM. 1995; 332: 19-25.
15. Hill MA, Araya JC, Eckert MW, et al. Tumor specific Epstein Barr virus infection is not associated with leiomyosarcoma in HIV negative individuals. Cancer. 1997; 80: 204-210.
16. Bayliss GJ, Wolf H. Epstein Barr virus induced cell fusion. Nature. 1980; 287: 164-165.
17. Spunt SL, Hill DA, Motosue AM, et al. Clinical features and outcome of initially unresected nonmetastatic pediatric nonrhabdomyosarcoma soft tissue sarcoma. J Clin Oncol. 2002; 20: 3225-3235.
18. Pappo SA, Devidas M, Jenkins J, et al. Phase II trial of neoadjuvant vincristine, ifosfamide, and doxorubicin with granulocyte colony-stimulating factor support in children and adolescents with advanced-stage nonrhabdomyosarcomatous soft tissue sarcomas: a Pediatric Oncology Group Study. J Clin Oncol. 2005; 23: 4031-4038.
19. Bay JO, Ray-Coquard I, Fayette J, et al. Docetaxel and gemcitabine combination in 133 advanced soft tissue sarcomas: a retrospective analysis. Int J Cancer. 2006; 119: 706-711.
20. Hensley ML, Maki R, Venkatraman E, et al. Gemcitabine and docetaxel in patients with unresectable leiomyosarcoma: results of phase II trial. J Clin Oncol. 2002; 20: 2824-2831.
21. Blumenthal DT, Raizer JJ, Rosenblum MK, et al. Primary intracranial neoplasms in patients with HIV. Neurology. 1999; 52: 1648-1651.
22. Slobod KS, Taylor GH, Sandlund JT, et al. Epstein-Barr virus-targeted therapy for AIDS-related primary lymphoma of the central nervous system. Lancet. 2000; 356: 1493-1494.
23. Von Hoff DD, McGill JR, Forseth BJ, et al. Elimination of extrachromosomally amplified MYC genes from human tumor cells reduces their tumorigenicity. Proc Natl Acad Sci USA. 1992; 89: 8165-8169.
24. Gottschalk S, Heslop HE, Rooney CM. Treatment of Epstein-Barr virus-associated malignancies with specific T cells. Adv Cancer Res. 2002; 84: 175-201.
25. Rooney CM, Smith CA, Ng CYC, et al. Infusion of cytotoxic T cells for the prevention and treatment of Epstein Barr Virus Induced lymphoma in allogenic transplant recipients. Blood. 1998; 92: 1549-1555.
26. Pakakasama S, Eames GM, Morris MC, et al. Treatment of Epstein Barr virus lymphoproliferative disease after hematopoietic stem cell transplantation with hydroxyurea and cytotoxic T cell lymphocytes. Transplantation. 2004; 78: 755-757.